Get started
Author

Mindy Huynh

Observed names: Huynh, Mindy, M. Huynh
ORCID: 0000-0002-0760-7783
Observed ORCID: 0000-0002-0760-7783
OpenAlex ID: A5080291744
Short-Term Exposure to a Western Diet Induces Psoriasiform Dermatitis by Promoting Accumulation of IL-17A–Producing γδ T Cells
2020 · Zhenrui Shi, Xuesong Wu, et al. · Journal of Investigative Dermatology · 80
Short-Term Western Diet Intake Promotes IL-23‒Mediated Skin and Joint Inflammation Accompanied by Changes to the Gut Microbiota in Mice
2021 · Zhenrui Shi, Xuesong Wu, et al. · Journal of Investigative Dermatology · 61
PDF
Bile Acids Improve Psoriasiform Dermatitis through Inhibition of IL-17A Expression and CCL20-CCR6–Mediated Trafficking of T Cells
2021 · Zhenrui Shi, Xuesong Wu, et al. · Journal of Investigative Dermatology · 54
PDF
Diagnostic Approach to Health Care- and Device-Associated Central Nervous System Infections
2018 · Ryan M. Martin, Lara L. Zimmermann, et al. · Journal of Clinical Microbiology · 53
Diet-induced obesity exacerbates imiquimod-mediated psoriasiform dermatitis in anti-PD-1 antibody-treated mice: Implications for patients being treated with checkpoint inhibitors for cancer
2020 · Sebastian Yu, Xuesong Wu, et al. · Journal of Dermatological Science · 50
A Small Molecule CCR2 Antagonist Depletes Tumor Macrophages and Synergizes with Anti–PD-1 in a Murine Model of Cutaneous T-Cell Lymphoma (CTCL)
2020 · Xuesong Wu, Rajinder Singh, et al. · Journal of Investigative Dermatology · 40
Targeting the CCR6/CCL20 Axis in Entheseal and Cutaneous Inflammation
2021 · Zhenrui Shi, Emma Garcia‐Melchor, et al. · Arthritis & Rheumatology · 33
PDF
Gain-of-function of TRPM4 predisposes mice to psoriasiform dermatitis
2022 · Daisuke Yamada, Simon Vu, et al. · Frontiers in Immunology · 12
Differential Requirement for CCR6 in IL-23–Mediated Skin and Joint Inflammation
2020 · Zhenrui Shi, Emma Garcia-Melchor, et al. · Journal of Investigative Dermatology · 11
A monocyte-keratinocyte-derived co-culture assay accurately identifies efficacies of BET inhibitors as therapeutic candidates for psoriasiform dermatitis
2020 · Xuesong Wu, Zhenrui Shi, et al. · Journal of Dermatological Science · 6
A modified ELISA assay differentiates CCL20 locked dimers from wild-type monomers
2023 · Xuesong Wu, William R. Clarke, et al. · Journal of Immunological Methods · 3
PDF
693 BET inhibitor OTX015 reduces imiquimod-induced mouse psoriasiform dermatitis
2019 · X. Wu, S. Yu, et al. · Journal of Investigative Dermatology · 1
Type F Infant Botulism Presenting at 11 Days of Age (P10-8.008)
2026 · Mindy Huynh, Priscilla Chee, et al. · Neurology
Idiopathic fibrosing pancreatitis: A rare cause of obstructive jaundice
2024 · Mindy Huynh, Rodolfo Silva, et al. · JPGN Reports
PDF
486 Glibenclamide ameliorates skin inflammation in a TRPM4 gain-of-function murine model of imiquimod-mediated psoriasiform dermatitis
2022 · D. Yamada, S. Vu, et al. · Journal of Investigative Dermatology
153 A specific mutation in TRPM4 predisposes mice to psoriasiform dermatitis (PsD)
2021 · D. Yamada, S. Vu, et al. · Journal of Investigative Dermatology
PDF
022 Diet-induced obesity predisposes anti-PD-1 antibody-treated mice to imiquimod-mediated psoriasiform dermatitis: implications for immune-related adverse events in cancer patients treated with anti-PD-1
2019 · S. Yu, X. Wu, et al. · Journal of Investigative Dermatology
687 BET inhibitor suppressed tumor growth and associated TME inflammation in mouse models of cutaneous T cell lymphoma
2019 · X. Wu, J. Chong, et al. · Journal of Investigative Dermatology
Works count: 19
Citation count: 402
H-index: 9
I10-index: 9
Year
Topic
Type